Reuters Events: Advocacy in Hemophilia

The global hemophilia ecosystem is rapidly evolving.

With an explosion in innovation, there are more sophisticated treatments, diagnostics, digital tools, physician resources and educational initiatives than ever before. At the same time, achieving sustainable access to these innovations is a significant challenge that’s exacerbated by an array of geographic and socio-economic factors.

The challenges of today require new thinking on how to face them so that people with hemophilia can pursue living their lives without limitations. With this, one thing is clear – rare blood disorders stakeholders must address these evolving challenges together to help advance higher standards of care for people with hemophilia across the globe.

That’s why Reuters Events, in partnership with Sanofi Genzyme, is proud to bring together leaders of the global hemophilia and rare disease advocacy communities, hematologists, policymakers, patients, payers and regulators to collectively explore sustainable solutions for accessing treatment, care and support.